Literature DB >> 12678872

Enhancing marine natural product structural diversity and bioactivity through semisynthesis and biocatalysis.

Mark T Hamann1.   

Abstract

In the last several decades the plants, animals and microbes from the marine environment have revealed a portion of what is clearly a tremendous resource for structurally diverse and bioactive secondary metabolites. Many of these extraordinarily sophisticated and bioactive natural products can be isolated in significant quantities without great difficulty. As a result these readily available bioactive natural products provide valuable starting materials for the rational generation of libraries of compounds prepared through semisynthesis and biocatalysis. A review of our work using marine natural products to generate rationally designed compound libraries and their biological activity against infectious diseases, cancer and neurological targets is presented. The marine natural products utilized to date as starting materials consist of compounds from a variety of structural classes and include: aureol, puupehenone, sarcophine, palinurin, and the manzamine alkaloids. The possibility to generate diverse bioactive products beginning with a marine natural product scaffold is a direct result of improvements made in the technologies to harvest samples from the ocean, purify and characterize complex natural products quickly and complete chemical reactions and biotransformations in parallel. As a result the vast resources of the ocean can now be utilized routinely to design and produce countless products to be evaluated as part of drug discovery and development programs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12678872     DOI: 10.2174/1381612033455297

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  8 in total

1.  Nature's bounty - drug discovery from the sea.

Authors:  John J Bowling; Anna J Kochanowska; Noer Kasanah; Mark T Hamann
Journal:  Expert Opin Drug Discov       Date:  2007-11       Impact factor: 6.098

Review 2.  Diversity through semisynthesis: the chemistry and biological activity of semisynthetic epothilone derivatives.

Authors:  Karl-Heinz Altmann; Fabienne Z Gaugaz; Raphael Schiess
Journal:  Mol Divers       Date:  2011-01-01       Impact factor: 2.943

3.  Bispuupehenone from the South Chinese Sea sponge Dysidea sp.

Authors:  Song Qin; Lei Shi; Jia Li; Yue-Wei Guo
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-04-30

4.  In Vitro Antibacterial Activity of Several Plant Extracts and Oils against Some Gram-Negative Bacteria.

Authors:  Ayman Al-Mariri; Mazen Safi
Journal:  Iran J Med Sci       Date:  2014-01

5.  Cytotoxic activity of rearranged drimane meroterpenoids against colon cancer cells via down-regulation of β-catenin expression.

Authors:  In Hyun Hwang; Joonseok Oh; Wei Zhou; Seoyoung Park; Joo-Hyun Kim; Amar G Chittiboyina; Daneel Ferreira; Gyu Yong Song; Sangtaek Oh; MinKyun Na; Mark T Hamann
Journal:  J Nat Prod       Date:  2015-01-15       Impact factor: 4.050

Review 6.  Indole alkaloid marine natural products: an established source of cancer drug leads with considerable promise for the control of parasitic, neurological and other diseases.

Authors:  Waseem Gul; Mark T Hamann
Journal:  Life Sci       Date:  2005-10-19       Impact factor: 5.037

Review 7.  Marine Rare Actinobacteria: Isolation, Characterization, and Strategies for Harnessing Bioactive Compounds.

Authors:  Dipesh Dhakal; Anaya Raj Pokhrel; Biplav Shrestha; Jae Kyung Sohng
Journal:  Front Microbiol       Date:  2017-06-15       Impact factor: 5.640

8.  Commentary on Traditional and Modern Biomedical Prospecting: Part II-The Benefits by Werner E.G. Muller, Heinz C. Schroder, Matthias Wiens, Sanja Perovic-Ottstadt, Renato Batel and Isabel M. Muller: Anti-protozoa and antiviral activities of non-cytotoxic truncated and variant analogues of mussel defensin by P. Roch, A. Beschin and E. Bernard.

Authors:  Edwin L Cooper
Journal:  Evid Based Complement Alternat Med       Date:  2004-09-01       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.